,Date,Study,Study Link,Journal,Study Type,Detection Method,Sample (n),Measure of Evidence (Sn & Sp),Speed of assay,FDA approval (Y/N),Added on,Study Population,Sample Text,Matches,Entry
,2020-08-31,COVID-19: From bench to bed side,https://doi.org/10.1016/j.dsx.2020.04.011,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,Other,,2.2,,,,,"Methods We systematically searched the PubMed database up till April 2, 2020 and retrieved all the articles published on SARS-CoV-2, SARS-CoV-1, MERS-CoV that dealt with viral dynamics.","The Chinese epidemic also doubled about every seven days and on average, each patient transmits the infection to an additional 2.2 individuals, suggesting the basic reproduction number (R0 or R naught) to be 2.2, which is a bit lesser compared to R0 of the SARS-CoV-1 epidemic of nearly 3.0, in 2002e2003 .",Rapid diagnostic tests will be helpful for screening and diagnosing COVID-19 patients.,2020-05-12
,2020-07-31,Pathogenic viruses: Molecular detection and characterization,https://doi.org/10.1016/j.meegid.2020.104215,"Infection, Genetics and Evolution",Other,,861.0,,,,,"Up to January 2020, WHO had reported 861 laboratory-confirmed cases of human infection with H5N1, 455 of which were fatal, resulting in a mortality rate of 53% (World Health Organization (WHO), 2020).","Up to January 2020, WHO had reported 861 laboratory-confirmed cases of human infection with H5N1, 455 of which were fatal, resulting in a mortality rate of 53% (World Health Organization (WHO), 2020).","Advances in molecular biology techniques have revolutionized the procedures for detection and characterization of pathogenic viruses.

Dramatic advances in molecular methods have revolutionized the detection and characterization of emerging viruses.

Advances in molecular biology techniques should be contingent with the development of more effective diagnostic tests for emerging viruses.

Molecular methods, in particular PCR and DNA sequencing technologies, have become the methods of choice for the detection and characterization of emerging and re-emerging pathogenic viruses.",2020-03-27
,2020-07-31,Five-minute point-of-care testing for SARS-CoV-2: Not there yet,https://doi.org/10.1016/j.jcv.2020.104410,Journal of Clinical Virology,Other,,,,,,,We suggest that repeat testing be performed in a clinical laboratory with EUA for patients with a moderate to high pre-test probability who test negative with this device.,We suggest that repeat testing be performed in a clinical laboratory with EUA for patients with a moderate to high pre-test probability who test negative with this device.,"As shown in this comparative diagnostic accuracy study, the performance of the 5-minute point-of-care test has significant limitations for the diagnosis of COVID-19.",2020-05-12
,2020-07-01,Electrochemical biosensors for pathogen detection,https://doi.org/10.1016/j.bios.2020.112214,Biosensors and Bioelectronics,Other,,5.0,,,,,We next discuss impedance-based electrochemical methods for detection of pathogens using electrochemical biosensors.,created a screen-printed graphite-based electrode for electrochemical detection of Vibrio parahaemolyticus (V. parahaemolyticus) based on 5 Î¼L samples (Zhao et al.,"Diagnostic assays based on traditional bioanalytical techniques for detection of pathogens in body fluids are the gold standard and serve an essential role in healthcare by enabling the diagnosis and treatment of various diseases.

A list of recent label-based approaches for pathogen detection using electrochemical biosensors, however, is provided in Table 2 .

Abstract Recent advances in electrochemical biosensors for pathogen detection are reviewed.

Biosensors offer a complementary diagnostic platform that enable rapid and costeffective measurements, high sensitivity, and the ability to make measurements in complex matrices that pose challenges to traditional bioanalytical techniques.",2020-05-12
,2020-05-06,The impact of biosensing in a pandemic outbreak: COVID-19,https://doi.org/10.1016/j.bios.2020.112274,Biosensors and Bioelectronics,Other,,2.0,,,,,"a (""COVID-19 and Coagulopathy -Hematology.org,"" 2020; ""Read Online-Handbook of COVID-19 Prevention and Treatment.pdf,"" 2020).","Besides, CRISPR-Biosensor's group would like to target two characteristic genome sequences (E gene and RdRP gene) of SARS-CoV-2 simultaneously, using a multiplexed microfluidic chip.","In this regard, other biosensing technologies offer a complementary approach to standard PCR-based tests not only in terms of sensitivity, but also in terms of diagnostics and therapeutic decisions.",2020-05-12
,2020-05-05,"An Environmental and Health Perspective for COVID-19 Outbreak: Meteorology and Air Quality Influence, Sewage Epidemiology Indicator, Hospitals Disinfection, Drug Therapies and Recommendations",https://doi.org/10.1016/j.jece.2020.104006,Journal of Environmental Chemical Engineering,Other,,4443.0,,,,,"Fortunately, in this study all air samples which were collected 2 to 5 m from the patients' beds with confirmed COVID-19 were negative.","Results show that out of the 4,443 fatality cases, 3,487 (78%) were in five regions located in North Italy and central Spain.",Paper-based devices are powerful and cheap tools for the rapid diagnosis of pathogens and determination infection of transmission .,2020-05-12
,2020-05-02,Beyond the Spike: identification of viral targets of the antibody response to SARS-CoV-2 in COVID-19 patients,https://doi.org/10.1101/2020.04.30.20085670,medrxiv,Other,,26.0,,,,,Methods: We evaluated the anti-SARS-CoV-2 antibody profiles to 15 SARS-CoV-2 antigens by cloning and expressing 15 open reading frames (ORFs) in mammalian cells and screened antibody responses to them in COVID-19 patients using the Luciferase Immunoprecipitation System (LIPS).,"Our study enrolled a total of 26 patients with RT-PCR confirmed COVID-19 infection 362 (Table 1) Table 1 , and primers sequences in 375","Although several serology tests are in use, improving their specificity and sensitivity for early diagnosis on the one hand and for detecting past infection for population-based studies, are priorities.",2020-05-12
,2020-05-01,Enabling and Emerging Technologies for Social Distancing: A Comprehensive Survey,https://doi.org/,ArXiv,Other,,,,,,,"In particular, the technique constructs a multivariate hidden Markov model through aggregating influenza morbidity data, influenza-related data from Google, and international air transportation data.",Remix consists of two processes.,"To improve the accuracy in detecting human from surveillance cameras, some advanced techniques can be implemented such as , and .",2020-05-12
,2020-04-30,Recent advances and perspectives of nucleic acid detection for coronavirus,https://doi.org/10.1016/j.jpha.2020.02.010,Journal of Pharmaceutical Analysis,Other,,6.0,,,,,"An efficient assay for the detection of SARS-CoV by RCA was set up in both liquid and solid phases , and presented preliminary results on a small number of clinical respiratory specimens.","It is commonly used for the amplification of DNAs and RNAs, which exhibits great sensitivity and high specificity as a result of its exponential amplification feature and 6 different target sequences identified by 4 different primers simultaneously, respectively .","Herein, a number of LAMP-based coronavirus detection methods have been developed and applied in clinical diagnosis.

Owing to its large range of applications, high sensitivity and high sequence specificity, the PCR-based method has become a routine and reliable technique for detecting coronaviruses .",2020-05-01
,2020-04-30,SnapShot: COVID-19,https://doi.org/10.1016/j.cell.2020.04.013,Cell,Other,,,,,,,"Blake Oberfeld, 1 Aditya Achanta, 1 Kendall Carpenter, 1 Pamela Chen, 1 Nicole M. Gilette, 1 Pinky Langat, 1 Jordan T. Said, 1 Abigail E. Schiff, 1,2, Allen S. Zhou, 1 Amy K. Barczak, 1,2 and Shiv Pillai In December 2019, several cases of pneumonia of unknown origin were reported in Wuhan, China.","Chest computed tomography (CT) scans of symptomatic patients are sensitive for detecting disease but nonspecific (CDC, 2020).","Reverse transcriptase-polymerase chain reaction of respiratory samples remains the gold standard for diagnosing COVID-19, though immunoassays, isothermal nucleic acid amplification tests, and CRISPR-based diagnostic tests are in development to facilitate rapid point-of-care testing and address global testing shortages (Pang et al., 2020) .",2020-05-12
,2020-04-29,The Diagnosis of Pandemic Coronavirus Pneumonia: A Review of Radiology Examination and Laboratory Test,https://doi.org/10.1016/j.jcv.2020.104396,Journal of Clinical Virology,Other,,,,,,,"In this review, we retrieved studies related to SARS, MERS, and COVID-19.","In COVID-19, 31% of lesion were unifocal, 69% were multifocal, 26% were unilobar, 74% were multilobar, 20% were unilateral, 80% were bilateral, 56% had lower lobe involvement, 82% were peripheral or subpleural, and 71% were central [37, 57] .","Compared with macroscopic morphological examinations, microcosmic etiological tests, including nucleic acid detection and serological detection, with high specificity, could serve as benchmarks for the laboratory detection of the virus In the past three decades, significant progress has been made in virus diagnostic testing, ranging from virus culture to rapid antigen detection, and recently to high-sensitivity NAAT, including PCR .

Currently, the mainstream diagnostic methods are imaging and laboratory diagnosis, which differ in their efficacy of diagnosis.",2020-05-01
,2020-04-25,Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19,https://doi.org/10.1016/j.mehy.2020.109786,Medical Hypotheses,Other,,6.0,,,,,"Although COVID-19 is generally thought to be milder compared to SARS and MERS-CoV, the full extent of the impact from COVID-19 remains pending.",LAMP exhibits increased sensitivity and specificity due to an exponential amplification feature that utilises 6 different target sequences simultaneously identified by separate distinct primers in the same reaction .,"and Prevention (CDCs) rapidly employed molecular assays for detection of COVID-19 in clinical samples These, and methods by other groups, mostly employed development of of quantitative RT-PCR characterized by rapid detection, high sensitivity and specificity, and are often described as a gold standard for virus detection .

Owing to its simplicity, high sensitivity, and high sequence specificity, PCR-based method are a routine and reliable method for detecting coronavirus infection in patients .",2020-05-01
,2020-04-22,Real-time RT-PCR in COVID-19 detection: issues affecting the results,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189409/,Expert Rev Mol Diagn,Other,,2.0,,,,,"In the second patient, SARS-CoV-2 was detected in both URT and LRT specimens on day 14 of symptom onset.","Viral load kinetics of SARS-CoV-2 infection have been described in two patients in Korea, suggesting a different viral load kinetics from that of previously reported other coronavirus infections .","Along with the advancement in medical diagnosis, nucleic acid detection-based approaches have become a rapid and reliable technology for viral detection.

Among nucleic acid tests, the polymerase chain reaction (PCR) method is considered as the 'gold standard' for the detection of some viruses and is characterized by rapid detection, high sensitivity, and specificity.",2020-05-12
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,Systematic review,,1063.0,,,,,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.","Our search retrieved 1,063 publications, of which 175 were duplicates.","Sequencing of specimens and clinical diagnosis have been used as alternative diagnostic approaches.

Possible diagnostic approaches are RT-PCR, serological assays and point-of-care testing.

Three reviews described methodologies, protocols and tools used for establishing the diagnosis of COVID-19 .",2020-05-01
,2020-04-19,Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients,https://doi.org/10.1101/2020.04.18.047878,biorxiv,Other,,3.0,,,,,Gargle solutions (20 ml in 0.9% NaCl) were obtained from three patients with confirmed COVID-19 infection.,Gargle solutions (20 ml in 0.9% NaCl) were obtained from three patients with confirmed COVID-19 infection.,"The future goal is to provide robust, sensitive, and reliable MS-based methods as a routine diagnostic of COVID-19 patients that complements PCR-based methods.",2020-04-24
,2020-04-18,Less is More: Intelligent Intensive Care for SARS-CoV-2 Based on the Imaging Data,https://doi.org/10.1016/j.jmir.2020.04.002,Journal of Medical Imaging and Radiation Sciences,Other,,800000.0,,,,,"To date, more than 800,000 coronavirus cases are diagnosed and nearly 40,000 deaths are reported globally.","To date, more than 800,000 coronavirus cases are diagnosed and nearly 40,000 deaths are reported globally.","In diagnostic models, imaging features are used for diagnosis or improving the diagnosis.",2020-05-12
,2020-04-18,Imaging of Coronavirus Disease 2019: A Chinese Expert Consensus Statement,https://doi.org/10.1016/j.ejrad.2020.109008,European Journal of Radiology,Other,,219.0,,,,,"In a study comparing chest CT from 219 patients with COVID-19 pneumonia in China and 205 patients with other causes of viral pneumonia in the United States, COVID-19 pneumonia cases were more likely to have a peripheral distribution (80 versus 57 percent), and GGO (91 versus 68 percent) .","In a study comparing chest CT from 219 patients with COVID-19 pneumonia in China and 205 patients with other causes of viral pneumonia in the United States, COVID-19 pneumonia cases were more likely to have a peripheral distribution (80 versus 57 percent), and GGO (91 versus 68 percent) .","The current gold standard for the diagnosis of COVID-19 is the detection of coronavirus nucleic acids, but imaging has an important role in the detection of lung lesions, stratification, evaluation of treatment strategies, and differentiation of mixed infections.",2020-04-24
,2020-04-17,Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis,https://doi.org/10.1101/2020.04.13.20064352,medrxiv,Systematic review,,49.0,,,,,"Methods: We searched studies reporting clinical characteristics in children with COVID-19 published until March 31, 2020.","Results: Our search retrieved 49 studies, including 25 case reports, 23 case series and one cohort study, with a total of 1667 patients.","Therefore, detection methods are particularly important for the diagnosis of COVID-19.",2020-04-24
,2020-04-15,Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172500/,ACS Nano,Other,,634000.0,,,,,"In December 2019, a series of cases of pneumonia of unknown cause were reported in Wuhan in the Hubei province of China.","4 As of March 29, 2020, more than 634,000 cases of COVID-19 have been confirmed around the world, resulting in 29,891 deaths.","17, 18 FET-based biosensors are considered to be potentially useful in clinical diagnosis, point-of-care testing, and on-site detection.",2020-05-12
,2020-04-15,"Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2",https://doi.org/10.1016/j.arcmed.2020.04.008,Archives of Medical Research,Other,,,,,,,"We were delighted to read the enlightening letter titled, The Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools submitted to the Archives of Medical Research .","The main rationale behind the recent advances in developing diagnostics for COVID-19 is achieving fast and cheap initial detection and confirmation of SARS-CoV-2 infection in different biological samples, including fecal samples, nasopharyngeal or oropharyngeal swabs, and environmental samples.","The diagnostic approaches, including RT-PCR, the CRISPR-based SHERLOCK (specific high-sensitivity enzymatic reporter UnLOCKing) technique, home-based point-of-care testing tools, and serological testing will definitely help with case-finding throughout the world when they become available and applied as routine tests.

The main rationale behind the recent advances in developing diagnostics for COVID-19 is achieving fast and cheap initial detection and confirmation of SARS-CoV-2 infection in different biological samples, including fecal samples, nasopharyngeal or oropharyngeal swabs, and environmental samples.",2020-04-24
,2020-04-13,Diagnostic Testing for Severe Acute Respiratory SyndromeâRelated Coronavirus-2: A Narrative Review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170415/,Ann Intern Med,Other,,926.0,,,,,We searched the PubMed database for articles on SARSâCoV-2 and diagnostics.,"As of 1 April 2020, the World Health Organization reported more than 926 000 cases in more than 195 countries, areas, or territories (3) .","Laboratory-based molecular assays for detecting SARS-CoV-2 in respiratory specimens are the current reference standard for COVID-19 diagnosis, but point-ofcare technologies and serologic immunoassays are rapidly emerging.

However, point-of-care technologies and serologic immunoassays are rapidly emerging.",2020-04-24
,2020-04-13,Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158889/,ACS Nano,Modeling,,167.0,,,,,All chemicals were purchased from commercial suppliers and used without further purification.,A recent study of 167 COVID-19 infection patients showed that five (3%) patients had positive chest computed tomography (CT) findings but false-negative results from the RT-PCR testing.,"21 Thus, the LSPR technique for genetic testing and nucleic acid detection in clinical practices could be an interesting alternative for SARS-CoV-2 detection and COVID-19 diagnosis.

Under the outbreak background of COVID-19, this proposed dual-functional LSPR biosensor can provide a reliable and easy-to-implement diagnosis platform to improve the diagnostic accuracy in clinical tests and relieve the pressure on PCR-based tests.",2020-04-24
,2020-04-08,Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody,https://doi.org/10.1101/2020.04.07.20053660,medrxiv,Case series,,2.1,,,,,confirmed cases of COVID-19 admitted to the people's hospital Affliated to Wuhan University.,2.1 Suspect cases: Considering both the following epidemiological history and clinical manifestations.,"According to the results of this study, combining the advantages and disadvantages of nucleic acid detection and antibody detection, the clinical pathway for clinicians to diagnose COVID-19 is found.",2020-04-17
,2020-04-06,Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR,https://doi.org/10.1101/2020.04.03.20052183,medrxiv,Other,,13.0,,,,,"Oropharingeal swap samples were suddenly analyzed for SARS-CoV-2 rt-PCR in Laboratory of Molecular Epidemiology and Public Health of the Hygiene Unit of Policlinico Hospital (Bari, Italy), which is the Regional Reference Laboratory for the SARS-CoV-2 identification.","However, all 13 patients withVivaDiag TM positive test and negative RT-PCR result (6.8%) were positive for IgM while only 7 subjects resulted positive for IgG.",Background RT-PCR test for identifiction of viral nucleic acid is the current standard diagnostic method for the diagnosis of COVID-19 disease but technical reasons limit the utilization of this assay on large scale screenings.,2020-04-10
,2020-04-06,"Global epidemiology, pathogenesis, immune response, diagnosis, treatment, economic and psychological impact, challenges, and future prevention of COVID-19: A scoping review",https://doi.org/10.1101/2020.04.02.20051052,medrxiv,Other,,5.0,,,,,"Articles, reports, preprints, expert opinions, and information from websites conducted among human participants, published in English language, and briefly showing the data regarding the current outbreak COVID-19 were included.","additionally, sera from 5 patients of confirmed COVID-19 showed some cross-reactivity with SARS-CoV.",The following laboratory diagnostic techniques are used to detect COVID-19,2020-04-10
,2020-04-04,COVID-19: A promising cure for the global panic,https://doi.org/10.1016/j.scitotenv.2020.138277,Science of The Total Environment,Other,,2494.0,,,,,"The WHO, on February 11, 2020, officially named the viral disease COVID-19 Guarner, 2020) .","This was closely followed by the emergence of MERS-CoV at Saudi Arabia in 2012, which caused 858 deaths among the 2494 known infected cases (Zaki et al., 2012) .","Imaging techniques can also be utilized as a diagnostic method in COVID-19.

During the SARS and MERS outbreaks effective diagnostic tools were developed for accurate detection.",2020-04-10
,2020-04-01,Fighting the Coronavirus Outbreak,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123858/,ACS Chem Biol,Other,,12.0,,,,,"9 At the center of the outbreak, a joint team led by Prof. Tiangang Liu at Wuhan University and Prof. Yan Li from the Renmin Hospital of Wuhan University developed a nanopore target sequencing (NTS) method to detect COVID-19 and other potential respiratory viruses simultaneously.","7 In collaboration with the You'an Hospital of Beijing Medical University, they collected blood samples from 12 convalescent patients, performed B-cell single cell sorting and library construction, and detected 15 000 IgG antibody sequences in 143 000 B cells.","In the early stage of the epidemic, clinicians relied on the traditional nucleic acid detection kit as the most precise method for diagnosis; however, it is timeconsuming with an inherent low positive detection rate.

In the early stage of the epidemic, clinicians relied on the traditional nucleic acid detection kit as the most precise method for diagnosis; however, it is time-consuming with an inherent low positive detection rate.",2020-04-10
,2020-03-31,"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China",https://doi.org/10.1016/j.micinf.2020.01.003,Microbes and Infection,Other,,887.0,,,,,"Abstract On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO).","As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries.",There are other molecular-based detection techniques in addition to RT-PCR and similar optimized detection techniques.,2020-04-10
,2020-03-30,"SARS-CoV-2 detection using digital PCR for COVID-19 diagnosis, treatment monitoring and criteria for discharge",https://doi.org/10.1101/2020.03.24.20042689,medrxiv,Other,,109.0,,,,,Double-blinded experiment data of 108 clinical specimens by dPCR methods were compared with results from officially approved RT-PCR assay.,A total of 109 samples including 108 clinical specimens and 1 negative control sample were tested in this study.,A high sensitivity RNA detection method to resolve the existing issues of RT-PCR is in need for more accurate COVID-19 diagnosis.,2020-04-03
,2020-03-29,Can AI help in screening Viral and COVID-19 pneumonia?,https://doi.org/,ArXiv,Other,,43.0,,,,,A public database was created by the authors using three public databases and by collecting images from recently published articles.,"Authors managed to collect 60 COVID-19 positive chest x-ray images from 43 recently published articles ,which were not listed in the GitHub database.","The high accuracy of this computer-aided diagnostic tool can significantly improve the speed and accuracy of diagnosing cases with COVID-19.

We believe that this computer aided diagnostic tool can significantly improve the speed and accuracy of diagnosing cases with COVID-19.",2020-05-01
,2020-03-27,Systematic review and critical appraisal of prediction models for diagnosis and prognosis of COVID-19 infection,https://doi.org/10.1101/2020.03.24.20041020,medrxiv,Systematic review,,5.0,,,,,"We searched PubMed, EMBASE via Ovid, bioRxiv, medRxiv, and arXiv for research on COVID-19 published after 3 rd January 2020.","Five studies carried out an external validation, 7 12 25 32 22 and only one study assessed calibration correctly.","-Viral nucleic acid testing and chest CT are standard methods for diagnosing COVID-19, but are time-consuming.",2020-04-10
,2020-03-23,Promising methods for detection of novel coronavirus SARSâCoVâ2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169335/,PMC,Other,,19.0,,,,,"As of February 6, 2020, 19 other genome sequences of SARS-CoV-2 obtained by using Illumina or Nanopore platforms were also uploaded on GenBank by researchers in China, 3, 4 the United States, and Australia.","As of February 6, 2020, 19 other genome sequences of SARS-CoV-2 obtained by using Illumina or Nanopore platforms were also uploaded on GenBank by researchers in China, 3, 4 the United States, and Australia.","Antibody-based immunoassay techniques combined with different signal detection methods are also found to be typically rapid detection methods.

Also, NTS combines sensitivity, comprehensiveness, rapid detection, and low cost, making it the most suitable method for the detection of suspected viral infection that cannot be diagnosed effectively by other methods.",2020-04-24
,2020-03-23,Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099676/,Environ Sci Technol,Other,,158.0,,,,,"About 158 111 confirmed cases and 5946 cumulative deaths (81 059 confirmed cases and 3204 cumulative deaths from China) have been reported around the globe as of March 15, 2020.","About 158 111 confirmed cases and 5946 cumulative deaths (81 059 confirmed cases and 3204 cumulative deaths from China) have been reported around the globe as of March 15, 2020.","Paper analytical devices have emerged as powerful tools for the rapid diagnosis of pathogens and determination of infection transmission.

Paper analytical devices enable multiplexed, sensitive assays that rival PCR laboratory assays and provide high-quality, fast precision diagnostics for pathogens.",2020-04-03
,2020-03-23,Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area,https://doi.org/10.1016/j.crad.2020.03.004,Clin Radiol,Case series,,114.0,,,,,"The study comprised 114 patients with confirmed COVID-19 treated at Xiaogan Hospital from 25 January 2020, to 9 February 2020, with complete medical records.","The study comprised 114 patients with confirmed COVID-19 treated at Xiaogan Hospital from 25 January 2020, to 9 February 2020, with complete medical records.","CONCLUSION: Spiral CT is a sensitive examination method, which can be applied to make an early diagnosis and for evaluation of progression, with a diagnostic sensitivity and accuracy better than that of nucleic acid detection.",2020-04-10
,2020-03-21,Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients,https://doi.org/10.1016/j.jinf.2020.03.013,Journal of Infection,Other,,32.0,,,,,"We analyzed a total of thirty-two COVID-19 patients admitted to Central Hospital of Xiangtan from January to February, 2020.","We analyzed a total of thirty-two COVID-19 patients admitted to Central Hospital of Xiangtan from January to February, 2020.",RT-PCR was a widely used tool in diagnosing SARS-CoV-2 infection.,2020-04-24
,2020-03-21,Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184472/,Clin Infect Dis,Other,,208.0,,,,,The grandparents returned to Beijing from Wuhan on 22 January 2020.,"In this study, a total of 208 blood samples were collected from 2 cohorts.","The epidemiology, etiology, and clinical characteristics of COVID-19 have recently been described in detail The current methods of diagnosis of COVID-19 includes detection of the virus by genomic techniques using either polymerase chain reaction (PCR)-based methods or deep sequencing .",2020-05-12
,2020-03-19,"Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096774/,Euro Surveill,Case series,,,,,,,"She was tested PCR-negative in 3 and 4 February samples and, as considered asymptomatic, discharged from hospital on 5 February.","She was tested PCR-negative in 3 and 4 February samples and, as considered asymptomatic, discharged from hospital on 5 February.","After understanding better the kinetics, specificity and sensitivity of the assays in development, the serological testing may help contact tracing of clusters and have a role in diagnosing acute and past SARS-CoV-2 infections.

The assay can be used as confirmatory tool for SARS-CoV-2 specificity in the development of more accessible diagnostic tools such as assays based on detecting binding antibodies.",2020-04-03
,2020-03-19,A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence,https://doi.org/10.1016/j.ijantimicag.2020.105948,International Journal of Antimicrobial Agents,Other,,214.0,,,,,"Consistently, SARS-CoV-2 RNA was also dectected in gastrointestinal tissues from COVID-19 patients .","In a study of 214 COVID-19 patients, 78 (36.4%) patients had neurological manifestations .",The detection of viral nucleic acid is the standard for noninvasive diagnosis of COVID-19.,2020-03-27
,2020-03-18,Point-of-Care RNA-Based Diagnostic Device for COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151043/,Diagnostics (Basel),Other,,145000.0,,,,,A recent study conducted by Prof. Jinzhao Song at the University of Pennsylvania in mid-February of 2020 describes a novel closed-tube COVID-19 assay that includes pathogen nuclei acid amplification and detection .,"As of March 14, 2020, the death toll has exceeded 5400, and there have been 145,000 confirmed cases, causing not only a huge medical health burden but also tremendous economic losses worldwide .","Currently, there are two primary methods for diagnosing COVID-19: a lateral flow immunoassay, which is a common point-of-care (POC) diagnostic approach that detects antibodies against specific viruses (e.g., SARS-CoV-2) in patient samples; and a molecular-based assay.",2020-04-24
,2020-03-14,High sensitivity detection of coronavirus SARS-CoV-2 using multiplex PCR and a multiplex-PCR-based metagenomic method,https://doi.org/10.1101/2020.03.12.988246,biorxiv,Modeling,,,,,,,"The plasmids containing either S or N gene of SARS-CoV-2 (pUC-S and pUC-N, respectively) were purchased from Sangon Biotech, Shanghai, China.","The two plasmids were diluted from approximately 9,000 copies to below one copy, and were amplified in multiplex PCR reactions.",AbstractMany detection methods have been used or reported for the diagnosis and/or surveillance of SARS-CoV-2.,2020-03-27
,2020-03-14,Accurate Identification of SARS-CoV-2 from Viral Genome Sequences using Deep Learning,https://doi.org/10.1101/2020.03.13.990242,biorxiv,Other,,402.0,,,,,"This resulted in 402 sequences, distributed as described in Table 2 .","This resulted in 402 sequences, distributed as described in Table 2 .","Molecular techniques, such as quantitative real-time RT-PCR and nucleic acid sequencing methods, are widely used to identify pathogens.",2020-04-10
,2020-03-10,Rapid AI Development Cycle for the Coronavirus (COVID-19) Pandemic: Initial Results for Automated Detection&Patient Monitoring using Deep Learning CT Image Analysis,https://doi.org/,ArXiv,Retrospective observational,,157.0,,,,,"50 abnormal thoracic CT scans (slice thickness, {5,7,8,9,10}mm) from China of patients that were diagnosed by a radiologist as suspicious for COVID-19 (from Jan-Feb 2020).",The study includes a testing set of 157 international patients (China and U.S).,"As illustrated above, using standard machine learning techniques and innovative AI applications, in combination with an established pulmonary CT detection platform, an effective tool can be utilized for the screening and early detection of patients who may have contracted the COVID-19 pathogen.",2020-05-01
,2020-02-26,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",https://doi.org/10.3390/jcm9030623,J Clin Med,Systematic review,,6.0,,,,,"For the 2019-nCoV, we searched for all in vitro, animal, or human studies published in English between 1 December 2019 and 6 February 2020, on the same outcomes of interest.","â¢ 13 specimens from 6 patients were positive with viral load range from 362 to 36,240,000 genome equivalents/mL.","These papers described diagnostic methods to detect the virus with the majority of them using molecular testing for diagnosis.

Among the 16 diagnostics studies selected, one study discussed the use of RT-PCR in diagnosing patients with 2019-nCoV (Table 1).

Among the 16 diagnostics studies selected, one study discussed the use of RT-PCR in diagnosing patients with 2019-nCoV ( Table 1 ).",2020-05-01
,2020-02-20,æ°åå ç¶çæ¯SARS-CoV-2çå®éªå®¤æ£æµææ¯,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086127/,PMC,Other,,,,,,,The ongoing epidemic of caused by the coronavirus SARS-CoV-2 starting in December 2019 poses a serious public health threat globally.,The selection of appropriate detection techniques and methods for accurate and rapid identification of pathogens therefore plays a key role in improving the diagnosis and treatment of the patients and containing the outbreak.,The selection of appropriate detection techniques and methods for accurate and rapid identification of pathogens therefore plays a key role in improving the diagnosis and treatment of the patients and containing the outbreak.,2020-04-03
,2020-02-18,Epidemic Situation of Novel Coronavirus Pneumonia in China mainland,https://doi.org/10.1101/2020.02.17.20024034,medrxiv,Other,,66492.0,,,,,"[Methods] From December 1, 2019 to February 14, 2020, Analysis of 66,492 confirmed cases of NCP in China mainland.","[Results] From December 1, 2019 to February 14, 2020, a total of 66,492 cases of NCP were confirmed in China mainland, a total of 54,406 cases were confirmed in Hubei Province, a total of 37,914 cases were confirmed in Wuhan city.",The gold standard for diagnosing pneumonia caused by novel coronavirus infection is nucleic acid detection .,2020-03-27
,2020-02-17,Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring,https://doi.org/10.1002/jmv.25702,J Med Virol,Other,,,,,,,"For example, during the month of January 2020, only 1700 specimens were tested (media report by the hospital on WeChat, 1/29/2020), compared with the vast number of clinic patients during that period (between 22 January and 30 January alone, there were over 7000 visits to one of the designated fever clinic).","Since 25 January tests have become increasingly available for clinically suspected patients, with a history of exposure, fever, and positive findings on chest CT.","2, 6 2 | DIAGNOSIS USING THE RNA-BASED ASSAYS Currently, the diagnosis of suspected cases is confirmed by RNA tests with real-time RT-PCR or next-generation sequencing.",2020-04-24
,2020-02-04,Recent advances in the detection of respiratory virus infection in humans,https://doi.org/10.1002/jmv.25674,J Med Virol,Other,,25.0,,,,,"30 The AccuPower MERSâCoV Real Time RTâPCR, LightMix Molecular Dx MERSâCoV upE/ORF1a, and UltraFast LabChip MERSCoV Realâtime PCR kits use two single geneâtargeting reagents to detect the upE and ORF1a genes simultaneously.","25 A total of 143 nasopharyngeal aspirate samples that tested RSVânegative by qRTâPCR were confirmed as RSVâpositive by sequencing the OTNRTâPCR products, 25 indicating that OTNRTâPCR is more sensitive than RTâqPCR for detection of RSV in clinical samples.","Emerging molecularâbased detection methods have gradually replaced traditional detection technology in many laboratories and clinical practices, providing reliable new methods for the diagnosis of hAdV.

With the development of modern technologies, new diagnostic strategies, including multiplex nucleic acid amplification and microarrayâbased assays, are emerging.",2020-04-24
0,2020-04-10,Evaluation of nine commercial SARS-CoV-2 immunoassays,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1,medRxiv,Retrospective Cohort,ELISA; Lateral Flow Assay,30.0,"The results showed 100% specificity for the Wantai SARS-CoV-2 Total Antibody ELISA, 93% for the Euroimmun IgA ELISA, and 96% for the Euroimmun IgG ELISA with sensitivities of 90%, 90%, and 65%, respectively",~2 hrs,Y,2020-04-25,,,,
1,2020-04-07,Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-Co2 virus detection,https://www.medrxiv.org/content/10.1101/2020.04.03.20052860v1,medRxiv,Simulation study,mini-PCR,,The fluorescence readings were 211 capable of clearly discriminating between positive and negative samples across the whole range of dilutions tested (from 2 Ã 105 212 to 625 copies),60 mins,N,2020-04-25,,,,
2,2020-04-04,Detecting SARS-CoV-2 at point of care: Preliminary data comparing Loop-mediated isothermal amplification (LAMP) to PCR,https://www.medrxiv.org/content/10.1101/2020.04.01.20047357v1,medRxiv,Simulation Study,"RT-LAMP, RT-PCR",24.0,"Using repeated RT-PCR as a 'gold standard', the sensitivity and specificity of the novel test were 80% and 73% respectively. Positive predictive value (PPV) was 73% and negative predictive value (NPV) was 83%.",<30 mins,Y,2020-04-25,,,,
3,2020-03-24,Diagnosing COVID-19: The Disease and Tools for Detection,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144809/,American Chemical Society,Review,Lateral Flow Antigen Detection; RT-LAMP; Microfluidic Devices; ,,"The lateral flow assay has demonstrated a clinical sensitivity, specificity, and accuracy of 57%, 100%, and 69% for IgM and 81%, 100%, and 86% for IgG, respectively. A test that detects both IgM and IgG yields a clinical sensitivity of 82%. [Microfluidics] showed 100% and 87% clinical sensitivity and specificity for HIV",1+ hours,Y,2020-04-25,,,,
4,2020-03-18,"All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus",https://www.biorxiv.org/content/10.1101/2020.03.19.998724v1,bioRxiv,Simulation Study,All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR),3.0,Both real-time and visual AIOD-CRISPR-based detections could detect down to 4.6 copies of SARS-CoV-2 N RNA targets in 40 min.,<40 min,Y,2020-04-25,,,,
5,2020-03-10,In silico approach to accelerate the development of mass spectrometry-based proteomics methods for detection of viral proteins: Application to COVID-19 biorxiv,https://www.biorxiv.org/content/10.1101/2020.03.08.980383v1,bioRxiv,Simulation Study,Shotgun Proteomics,,Theoretical trypsin digest of the 2019-nCoVpFASTA1 database produced tryptic peptides with average lengths of 8 to 18 amino acids. These results indicate that trypsin digestion is an appropriate choice for detection of these viral proteins,6 hours,N,2020-04-25,,,,
6,2020-03-09,Sensitive one-step isothermal detection of pathogen-derived RNAs medrxiv,https://www.medrxiv.org/content/10.1101/2020.03.05.20031971v2,medRxiv,Simulation,SENSR (Novel pathogen diagnostic technique),,"All four probe pairs were able to detect 1 aM of SARS267 CoV-2 RNA, thereby exhibiting higher fluorescence intensity compared to that of the related 268 viral RNA sequences",30 mins,N,2020-04-25,,,,
7,2020-03-02,CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design biorxiv,https://www.biorxiv.org/content/10.1101/2020.02.26.967026v2,biorxiv,Simulation,CRISPR,,Limit of detection of synthetic RNA target determined to be 10 copies/Âµl using both fluorescent and lateral flow detection. This assay performs well in comparison to the recently disclosed DETECTR assay (sensitivity: 70â300 cp/Âµl) and SHERLOCK assay (10â100 cp/Âµl) for SARS-CoV-2.,30 mins to 3 hrs,Y,2020-04-25,,,,
8,2020-03-02,Fecal specimen diagnosis 2019 novel coronavirusâinfected pneumonia,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25742?casa_token=ho46WmikWXAAAAAA%3AGisen6_A6UoE2JVWPUO3jrkHnQB7J-nYhXZZfoxzkeWAzct4wlJZceUsOJMrb8gCFtnTCsKV3X6tMH8,Journal of Medical Virology,Retrospective Cohort,RT-PCR,14.0,"Five of the 14 confirmed patients (35.7%) had a positive stool sample COVIDâ19 nucleic acid, and patients with positive stool samples were also positive for oropharyngeal swabs specimens at least the day before",>24 hrs,Y,2020-04-25,,,,
9,2020-03-01,Pixelated colorimetric nucleic acid assay,https://www.sciencedirect.com/science/article/pii/S0039914019312147?via%3Dihub,Talanta,Simulation Study,Pixelated colorimetric nucleic acid assay,,"Successful detection of HBV DNA was demonstrated in plasma, mimicking clinical samples, with a detection limit of 1 nM.",5-45 minutes,N,2020-04-25,,,,
10,2020-02-27,A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2 biorxiv,https://www.biorxiv.org/content/10.1101/2020.02.22.961268v1,medRxiv,Investigative Study,RT-PCR (Novel Procedure),,"pcMNPs have excellent viral RNA binding performances, which results in 10-copy sensitivity and the high linearity over 5 logs of gradient in SARSCoV-2 viral RNA detection using RT-PCR",20 mins,N,2020-04-25,,,,
11,2020-02-26,2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142866/,Micromachines,Review ,rRT-PCR; RT-LAMP; Serology,,"RT-LAMP Sensitivity >95%; PCR Diagnostic sensitivity of 95%, Sensitivity of Serology 88.66%",RT-LAMP <1 hr; PCR 2-3 days;,Y,2020-04-25,,,,
12,2020-02-25,Development and Evaluation of A CRISPR-based Diagnostic 2 For 2019-novel Coronavirus,https://www.medrxiv.org/content/10.1101/2020.02.22.20025460v2,medRxiv,Simulation Study,"CRISPR, mNGS, rRT-PCR",52.0,"PCR- and CRISPR-nCoV both had a specificity of 239 100% in our study.PCR-nCoV was able to detect the virus in 90.4% (47/52) of the positive 240 cases, with Ctâs ranging from 28.8 to 40.4 and a median Ct of 35.8. CRISPR showed a greater sensitivity [than PCR] by detecting all 52 244 nCoV-confirmed cases (100%), with FC values ranging from 5.0 to 66.3 and a median FC of 245 22.8 (Figure 4A).",40 mins,Y,2020-04-25,,,,
